Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus

Journal of Immunology

Volumn 177, Issue 10, 2006, Pages 7423-7434

  Sekine, Hideharu ^a,d   Graham, Kareem L ^b   Zhao, Shenre ^b   Elliott, Margaret K ^a   Ruiz, Philip ^c   Utz, Paul J ^b   Gilkeson, Gary S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; H2 ANTIGEN; IMMUNOGLOBULIN G3; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONGENIC ANIMAL; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE IDENTIFICATION; GENETIC LINKAGE; HISTOPATHOLOGY; IMMUNE COMPLEX DEPOSITION; IMMUNOGLOBULIN DEFICIENCY; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR HISTOCOMPATIBILITY COMPLEX; MHC2 GENE; MHCI GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; SCORING SYSTEM; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 33750816202     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.10.7423     Document Type: Article

References (62)

1. Forbes, S. A., and J. Trowsdale. 1999. The MHC quarterly report. Immunogenetics 50: 152-159.
2. Gruen, J. R., and S. M. Weissman. 1997. Evolving views of the major histocompatibility complex. Blood 90: 4252-4265.
3. Allcock, R. J., A. M. Martin, and P. Price. 2000. The mouse as a model for the effects of MHC genes on human disease. Immunol. Today 21: 328-332.
4. Morahan, G., and L. Morel. 2002. Genetics of autoimmune diseases in humans and in animal models. Curr. Opin. Immunol. 14: 803-811.
5. Kotzin, B. L. 1996. Systemic lupus erythematosus. Cell 85: 303-306.
6. Wakeland, E. K., K. Liu, R. R. Graham, and T. W. Behrens. 2001. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15: 397-408.
7. Gaffney, P. M., W. A. Ortmann, S. A. Selby, K. B. Shark, T. C. Ockenden, K. E. Rohlf, N. L. Walgrave, W. P. Boyum, M. L. Malmgren, M. E. Miller, et al. 2000. Genome screening in human systemic lupus erythematosus. Am. J. Hum. Genet. 66: 547-556.
8. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37: 269-390.
9. Ibnou-Zekri, N., T. J. Vyse, S. J. Rozzo, M. Iwamoto, T. Kobayakawa, B. L. Kotzin, and S. Izui. 1999. MHC-linked control of murine SLE. Curr. Top. Microbiol. Immunol. 246: 275-280.
10. Vidal, S., D. H. Kono, and A. N. Theofilopoulos. 1998. Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. J. Clin. Invest. 101: 696-702.
11. Jevnikar, A. M., M. J. Grusby, and L. H. Glimcher. 1994. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179: 1137-1143.
12. Andrews, B. S., R. A. Eisenberg, A. N. Theofilopoulos, S. Izui, C. B. Wilson, P. J. McConahey, E. D. Murphy, J. B. Roths, and F. J. Dixon. 1978. Spontaneous murine lupus-like syndromes. J. Exp. Med 148: 1198-1215.
13. Schur, P. H. 1989. Clinical feature of SLE. In Textbook of Rheumatology. W. N. Kelly, E. D. Harris, S. Ruddy, and C. B. Sledge, eds. W. B, Saunders, Philadelphia, pp. 1101-1111.
14. Couser, W. G., D. J. Salant, M. P. Madaio, S. Adler, and G. C. Groggel. 1982. Factors influencing glomerular and tubulointerstitial patterns of injury in SLE. Am. J. Kidney Dis. 2: 126-134.
15. Glassock, R. J., A. H. Cohen, S. G. Adler, and H. J. Ward. 1991. Secondary glomerular disease. In The Kidney. B. M. Brenner and F. C. Rector, eds. W. B. Saunders, Philadelphia, pp. 1280-1288.
16. Winfield, J. B., I. Faiferman, and D. Koffler. 1977. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. J. Clin. Invest. 59: 90-96.
17. Pankewycz, O. G., P. Migliorini, and M. P. Madaio. 1987. Polyreactive autoantibodies are nephritogenic in murine lupus nephritis. J. Immunol. 139: 3287-3294.
18. Takahashi, S., M. Nose, J. Sasaki, T. Yamamoto, and M. Kyogoku. 1991. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J. Immunol. 147: 515-519.
19. Reininger, L., T. Berney, T. Shibata, F. Spertini, R. Merino, and S. Izui. 1990. Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms. Proc. Natl. Acad. Sci. USA 87: 10038-10042.
20. Izui, S., T. Berney, T. Shibata, and T. Fulpius. 1993. IgG3 cryoglobulins in autoimmune MRL-lpr mice. Ann. Rheum. Dis. (52 Suppl. 1): S48-S54.
21. 2-microglobulin. J. Immunol. 154: 2063-2074.
22. Robinson, W. H., C. DiGennaro, W. Hueber, B. B. Haab, M. Kamachi, E. J. Dean, S. Fournel, D. Fong, M. C. Genovese, H. E. de Vegvar, et al. 2002. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 8: 295-301.
23. Haab, B. B., M. J. Dunham, and P. O. Brown. 2001. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2: RESEARCH 4.0001-4.0013.
24. Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98: 5116-5121.
25. Storey, J. D. 2002. A direct approach to false discovery rates. J. R. Stat. Soc. Ser. B Stat. Methodol. 64: 479-498.
26. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95: 14863-14868.
27. Sekine, H., C. M. Reilly, I. D. Molano, G. Garnier, A. Circolo, P. Ruiz, V. M. Holers, S. A. Boackle, and G. S. Gilkeson. 2001. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J. Immunol. 166: 6444-6451.
28. Eisenberg, R. A., J. B. Winfield, and P. L. Cohen. 1982. Subclass restriction of anti-Sm antibodies in MRL/lpr mice. J. Immunol. 129: 2146-2149.
29. Lefkowith, J. B., and G. S. Gilkeson. 1996. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum. 39: 894-903.
30. lpr mice. J. Immunol. 172: 3913-3921.
31. Watanabe, H., G. Gamier, A. Circolo, R. A. Wetsel, P. Ruiz, V. M. Holers, S. A. Boackle, H. R. Colten, and G. S. Gilkeson. 2000. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J. Immunol. 164: 786-794.
32. Robinson, W. H., P. Fontoura, B. J. Lee, H. E. de Vegvar, J. Tom, R. Pedotti, C. D. DiGennaro, D. J. Mitchell, D. Fong, P. P. Ho, et al. 2003. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat. Biotechnol. 21: 1033-1039.
33. Neuman de Vegvar, H. E., R. R. Amara, L. Steinman, P. J. Utz, H. L. Robinson, and W. H. Robinson. 2003. Microarray profiling of antibody responses against simian-human immunodeficiency virus. J. Virol. 77: 11125-11138.
34. Hueber, W., B. A. Kidd, B. H. Tomooka, B. J. Lee, B. Bruce, J. F. Fries, G. Sonderstrup, P. Monach, J. W. Drijfhout, W. J. van Venrooij, et al. 2005. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum. 52: 2645-2655.
35. Zhen, Q. L., C. Xie, T. Wu, M. Mackay, C. Aranow, C. Putterman, and C. Mohan. 2005. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J. Clin. Invest. 115: 3428-3439.
36. Sharp, G. C., W. S. Irvin, C. M. May, H. R. Holman, F. C. McDuffie, E. V. Hess, and F. R. Schmid. 1976. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N. Engl. J. Med. 18: 1149-1154.
37. Cohen, P. L., E. Creech, D. Nakul-Aquaronne, R. McDaniel, S. Ackler, R. G. Rapoport, E. S. Sobel, and R. A. Eisenberg. 1993. Antigen nonspecific effect of major histocompatibility complex haplotype on autoantibody levels in systemic lupus erythematosus-prone lpr mice. J. Clin. Invest. 91: 2761-2768.
38. Arnett, F. C. 2000. Genetic studies of human lupus in families. Intern. Rev. Immunol. 19: 297-317.
39. Olsen, M. L., F. C. Arnett, and J. D. Reveille. 1993. Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitin autoantibodies in systemic lupus erythematosus. Arthritis Rheum. 36: 94-104.
40. Arnett, F. C. 1997. The genetics of human lupus. In Dubois' Lupus Erythematosus, 5th Ed. D. J. Wallace and B. H. Hahn, eds. Williams & Wilkins, Baltimore, pp. 77-117.
41. Merino, R., L. Fossati, M. Lacour, R. Lemoine, M. Higaki, and S. Izui. 1992. H-2-linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice. Eur. J. Immunol. 22: 295-299.
42. 1 hybrid mice. J. Clin. Invest. 94: 521-525.
43. Ibnou-Zekri, N., M. Iwamoto, L. Fossati, P. J. McConahey, and S. Izui. 1997. Role of the major histocompatibility complex class II Ea gene in lupus susceptibility in mice. Proc. Natl. Acad. Sci. USA 94: 14654-14659.
44. Ibnou-Zekri, N., M. Iwamoto, M. E. Gershwin, and S. Izui. 2000. Protection of murine lupus by the Ead transgene is MHC haplotype-dependent. J. Immunol. 164: 505-511.
45. Mathis, D. J., C. Benoist, V. E. Williams II, M. Kanter, and H. O. McDevitt. 1983. Several mechanisms can account for defective Eα gene expression in different mouse haplotypes. Proc. Natl. Acad. Sci. USA 80: 273-277.
46. Kong, P. L., T. Zhu, M. P. Madaio, and J. Craft. 2003. Role of the H-2 haplotype in Fas-intact lupus-prone MRL mice. Arthritis Rheum. 48: 2992-2995.
47. Chan, O. T., L. G. Hannum, A. M. Haberman, M. P. Madaio, and M. J. Shlomchik. 1999. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189: 1639-1648.
48. Matthews, V. B., F. T. Christiansen, and P. Price. 2000. A novel locus affecting serum levels of IgG2a maps to the murine H2 region. Eur. J. Immunogenet. 27: 135-139.
49. Matthews, V. B., G. Morahan, and P. Price. 2001. A locus affecting immunoglobulin isotype selection (Igis1) maps to the MHC region in C57BL, BALB/c and NOD mice. Immunol. Cell Biol. 79: 576-582.
50. Cunningham-Rundles, C., M. Fotino, O. Rosina, and J. B. Peter. 1991. Selective IgA deficiency, IgG subclass deficiency, and the major histocompatibility complex. Clin. Immunol. Immunopathol. 61: S61-S69.
51. Matthews, V. B., C. S. Witt, M. A. French, H. K. Machulla, E. G. De la Concha, K. Y. Cheong, P. Vigil, P. N. Hollingsworth, K. J. Warr, F. T. Christiansen, and P. Price. 2002. Central MHC genes affect IgA levels in the human: reciprocal effects in IgA deficiency and IgA nephropathy. Hum. Immunol. 63: 424-433.
52. Eisenberg, R. A., S. Y. Craven, R. W. Warren, and P. L. Cohen. 1987. Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J. Clin. Invest. 80: 691-697.
53. Gyotoku, Y., M. Abdelmoula, F. Spertini, S. Izui, and P. H. Lambert. 1987. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/lpr mice. J. Immunol. 138: 3785-3792.
54. Fulpius, T., F. Spertini, L. Reininger, and S. Izui. 1993. Immunoglobulin heavy chain constant region determines the pathogenicity and the antigen-binding activity of rheumatoid factor. Proc. Natl. Acad. Sci. USA 90: 2345-2349.
55. Smoyer, W. E., and P. Mundel. 1998. Regulation of podocyte structure during the development of nephrotic syndrome. J. Mol. Med. 76: 172-183.
56. Sinniah, R., and P. H. Feng. 1976. Lupus nephritis: correlation between light, electron microscopic and immunofluorescent findings and renal function. Clin. Nephrol. 6: 340-351.
57. Hall-Craggs, M., and E. Ramos. 1981. Transformation of diffuse proliferative glomerulonephritis to membranous nephritis in a patient with SLE. Nephron 28: 42-45.
58. Tornroth, T., E. Honkanen, and E. Pettersson. 1987. The evolution of membranous glomerulonephritis reconsidered. Clin. Nephrol. 28: 107-117.
59. Ben-Bassat, M., J. Rosenfeld, H. Joshua, B. Hazaz, and V. Gura. 1979. Lupus nephritis: electron-dense and immunofluorescent deposits and their correlation with proteinuria and renal function. Am. J. Clin. Pathol. 72: 186-193.
60. Gessner, J. E., H. Heiken, A. Tamm, and R. E. Schmidt. 1998. The IgG Fc receptor family. Ann. Hematol. 76: 231-248.
61. Matsumoto, K., N. Watanabe, B. Akikusa, K. Kurasawa, R. Matsumura, Y. Saito, I. Iwamoto, and T. Saito. 2003. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MKL/lpr mice. Arthritis Rheum. 48: 486-494.
62. Han, Y., T. R. Kozel, M. X. Zhang, R. S. MacGill, M. C. Carroll, and J. E. Cutler. 2001. Complement is essential for protection by an IgM and an IgG3 monoclonal antibody. J. Immunol. 167: 1550-1557.